Skip to main content

Table 2 HPV prevalence and type distribution (N = 87a)

From: Molecular analysis of human Papillomavirus detected among women positive for cervical lesions by visual inspection with acetic acid/Lugol’s iodine (VIA/VILI) in Libreville, Gabon

HPV type

nb (%)

Single infection

Multiple infections

HPV-positive

52 (59.77)

30 (57.69)

22 (42.31)

High-risk (HR-HPV)

 HPV16

40 (76.92)

19 (47.5)

21 (52.5)

 HPV18

11 (21.15)

4 (36.36)

7 (63.64)

 HPV31

1 (1.78)

0

1 (100)

 HPV33

13 (25.00)

2 (50)

9 (69.23)

 HPV35

2 (3.57)

1 (50)

1 (50)

 HPV45

7 (12.5)

0

7 (100)

 HPV58

6 (10.71)

1 (16.67)

5 (83.33)

Low-risk (LR-HPV)

 HPV32

2 (3.85)

1 (50)

1 (50)

 HPV62

1 (1.78)

0

1 (100)

 HPV72

9 (17.31)

1 (11.10)

8 (88.90)

 HPV81

1 (1.78)

0

1 (100)

 HPV90

1 (1.78)

1 (100)

0

 HPV87

1 (1.78)

0

1 (100)

  1. aNumber of tested cervical samples
  2. bNumber of subjects in a given category